Home LiteratureArticle Details
PMID: 4031892 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Involvement of an "antizyme" in the inactivation of ornithine decarboxylase.

Journal of neurochemistry ·Vol. 45 ·No. 4 ·1985-10-00 ·Pages 1303-7

Laitinen PH

Abstract

DL-Allylglycine causes a marked increase in mouse brain ornithine decarboxylase (ODC) activity. The amount of immunoreactive enzyme protein increases concomitantly with the activity, but the enzyme protein decreases more slowly than that of the activity. The amount of immunoreactive ODC in brain is many hundred times that of the catalytically active enzyme. The fact that mouse brain cytosol contains high amounts of dissociable antizyme (an inactivating protein) indicates the existence of an inactive, immunoreactive ODC-antizyme pool. The total antizyme content does not change markedly, but instead there are significant changes in different antizyme pools. Putrescine concentrations start to increase 8 h after treatment with allylglycine and concomitantly with this increase, antizyme is released to inhibit enzyme activity. These results indicate the involvement of antizyme in the inactivation process of ODC.

MeSH Terms
Allylglycine/administration & dosage,pharmacology Animals Brain/drug effects,enzymology Female Injections, Intraperitoneal Mice Ornithine Decarboxylase Inhibitors Putrescine/metabolism Time Factors
Chemicals
Ornithine Decarboxylase Inhibitors Allylglycine Putrescine
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Laitinen P H
Article Info
Journal
Journal of neurochemistry
Abbr.
J Neurochem
ISSN
0022-3042
Published
1985-10-00
Pages
1303-7
Language
English
Region
England
NLM ID
2985190R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]